Complementing Tissue Testing With Plasma Mutation Profiling Improves Therapeutic Decision-Making for Patients With Lung Cancer

BACKGROUND: Tissue biopsy is an integral part of the diagnostic approach to lung cancer. It is however invasive and limited by heterogeneity. Liquid biopsies may complement tissue testing by providing additional molecular information and may be particularly helpful in patients from whom obtaining su...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, Yukti, Tan, Min-Han, Shi, Jun Li, Tee, Augustine, Ngeow, Kao Chin, Poh, Jonathan, Goh, Ruth Rosalyn, Mong, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873935/
https://www.ncbi.nlm.nih.gov/pubmed/35223889
http://dx.doi.org/10.3389/fmed.2022.758464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873935/
https://www.ncbi.nlm.nih.gov/pubmed/35223889
http://dx.doi.org/10.3389/fmed.2022.758464

Ejemplares similares